Chinese Journal of Practical Pediatrics ›› 2021, Vol. 36 ›› Issue (11): 839-842.DOI: 10.19538/j.ek2021110608
Previous Articles Next Articles
Online:
Published:
通讯作者:
Abstract: Juvenile dermatomyositis is one of the rare rheumatic diseases in children. The common treatment is hormone combined with slow-acting drugs. It is difficult to choose slow-acting drugs,swith drugs and design course of treatment because of the low incidence and lack of large randomized controlled trials. The author summarizes the common slow-acting antirheumatic drugs used in the treatment of juvenile dermatomyositis,and introduces the mechanism of action,dosage,adverse reactions and indications of these drugs,in order to help doctors to select drugs.
Key words: juvenile dermatomyositis, slow- acting antirheumatic drug, treatment
摘要: 幼年皮肌炎是儿童少见的风湿性疾病之一,常用的治疗方案是激素联合慢作用药物。由于发病率较低,缺少大样本随机对照试验研究,选择哪种慢作用药物、了解药物之间的转换以及确定疗程是比较困难的。该文对治疗幼年皮肌炎的常用慢作用药物及其作用机制、剂量、不良反应和适应证进行介绍,有助于临床医师对药物选择进行权衡。
关键词: 幼年皮肌炎, 慢作用抗风湿药物, 治疗
LIU Li, SUN Yan- ru, HU Jian. Advances of slow- acting antirheumatic drug for juvenile dermatomyositis[J]. Chinese Journal of Practical Pediatrics, 2021, 36(11): 839-842.
刘 力 , 孙艳茹 , 胡 坚. 幼年皮肌炎慢作用药物治疗进展[J]. 中国实用儿科杂志, 2021, 36(11): 839-842.
0 / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgsyz.com/zgsyek/EN/10.19538/j.ek2021110608
http://www.zgsyz.com/zgsyek/EN/Y2021/V36/I11/839